Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

MSD and WuXi Biologics – which have been collaborating ... Alzheimer's therapy donanemab as well as other biologics, and AstraZeneca's recently opened, $360 million active pharmaceutical ...

AstraZeneca has confirmed that some of its ... and R&D centre in Shanghai and a network of supply sites in Wuxi, Taizhou, and Qingdao, employing around 16,000 people. China has expanded rapidly ...

Fibrogen said the deal will give AstraZeneca full rights to its anemia drug roxadustat in China. In December, AstraZeneca, ...

The global biotechnology market was worth USD 1.68 trillion in 2024 and is expected to surge around USD 3.54 Trillion by 2033, with a noteworthy CAGR of 9.18% from 2024 to 2033. The growing demand for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...